Member Info for BusinessOwner

Paul1828. Please stop embarrassing yourself. If you had any idea what you were talking about, you would know these things take time. Move along.

They will take 5m off me in one hit. Just fun and games. Give it a few months and we will know the direction, whether up or down.

Let the company do the talking, not the amateur punters who think this is a betting app.

Pumpers or dumpers will have zero effect on the overall direction of this share price long term. They will either have a big viable find or they will not.

Everything else in between is simply speculation by non-professionals on a bulletin board.

PE ratio for Pharmas is a good 15-20. Nice.

MIKODX. Anyone using the abbreviation LOL is simply not to betaken seriously. Move along.

MIKODX. Please stop with your nonsense. You are not Warren Buffett. Predicting an AIM share will have a placing is like predicting that your local Tesco will be selling food tomorrow. 🙄

Cando. Are you inventing figures, because that is simply not true.

Well I first one have £45k in my isa waiting for a dip below 9.5p. We shall see.

David. They are likely to comeback and say over-subscribed and issue more to retail. It happens quite a lot. I will ask for 100k, with other funds available if I can buy below 9.5p.

When buying Shares in the aim market, one always has to factor in two things.

1. Companies only list on aim to raise funds, so a raise is inevitable

2. Have funds available to either buy lower or partake in a raise if you feel the business is moving forward.

This will give a solid footing moving forward with the collaboration. Short-term volatility, balanced against long-term growth.

You have a bit of time to decide whether to buy in the Raise. Do not rush, as if these drop below 9.5 you will get them cheaper, if it stays above 9.5, why you can let your broker know this week you want some.

Comek. I’m not in linkedin, so hope this works.

https://www.linkedin.com/posts/ryanfukushima_renalytix-announces-collaboration-with-tempus-activity-7373400615487508480-CRMf

Ignore last Rocket. Found on LinkedIn. Many thanks.

At Tempus AI, we've seen brilliant diagnostic algorithms struggle to find their footing in clinical practice.

The pattern is always the same: Amazing accuracy in controlled studies ✓ Regulatory approval ✓ Reimbursement pathway ✓ Clinical workflow integration... ❌

Renalytix cracked this code.

Their test doesn't just predict risk levels—it delivers actionable insights directly into existing clinical workflows.

Can you post a link to that tweet please. I follow all

The Tempus main players and i havent seen that. Thanks.

Adam khan. You might want to do some research on Pharmas as you appear to hold them. The average Pharmaceutical P/E ratio can vary, but data from 2025 indicates it is around 18.72 for pharmaceutical companies and a broader average of about 28.7 for the top pharmaceutical companies.

On a 100% growth trajectory, this is not even close to value yet.

Well let’s just go with, the appetite here seems to be waning.

Just taken another 66k at 10.25p. That's my lot now at 600k. See how she goes.

Bobat123. I assume that is code for ‘I don’t hold any here, but please buy some OMI as I’m underwater’.

MIKODX. Please take your nonsense elsewhere. They have clearly stated:

Significant progress to reduce overall cash burn rate to c.£560,000 ($710,000) per month by end of FY FY25 as stated in the Company's FY24 results announcement

Literally the only reason companies list on AIM is to raise funds due to no other options being available. To predict a placing is to predict that a newly built ALDI will sell food. It doesn’t make you Warren Buffett.

The trick is to know whether the placing and dilution is warranted for growth or just to line pockets of the Board. Often at the right time a placing is worthwhile. Other times it may be a slippery slope. Time will tell.